Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs

ACS Nano. 2022 Apr 26;16(4):5184-5232. doi: 10.1021/acsnano.2c01252. Epub 2022 Mar 29.

Abstract

In addition to the contribution of cancer cells, the solid tumor microenvironment (TME) has a critical role in determining tumor expansion, antitumor immunity, and the response to immunotherapy. Understanding the details of the complex interplay between cancer cells and components of the TME provides an unprecedented opportunity to explore combination therapy for intervening in the immune landscape to improve immunotherapy outcome. One approach is the introduction of multifunctional nanocarriers, capable of delivering drug combinations that provide immunogenic stimuli for improvement of tumor antigen presentation, contemporaneous with the delivery of coformulated drug or synthetic molecules that provide immune danger signals or interfere in immune-escape, immune-suppressive, and T-cell exclusion pathways. This forward-looking review will discuss the use of lipid-bilayer-encapsulated liposomes and mesoporous silica nanoparticles for combination immunotherapy of the heterogeneous immune landscapes in pancreatic ductal adenocarcinoma and triple-negative breast cancer. We describe how the combination of remote drug loading and lipid bilayer encapsulation is used for the synthesis of synergistic drug combinations that induce immunogenic cell death, interfere in the PD-1/PD-L1 axis, inhibit the indoleamine-pyrrole 2,3-dioxygenase (IDO-1) immune metabolic pathway, restore spatial access to activated T-cells to the cancer site, or reduce the impact of immunosuppressive stromal components. We show how an integration of current knowledge and future discovery can be used for a rational approach to nanoenabled cancer immunotherapy.

Keywords: combination therapy; immune escape; immune landscapes; immune suppression; immunogenic cell death; liposomes; nanocarrier; pancreas cancer; silicasomes; spatial distribution; triple-negative breast cancer.

Publication types

  • Review
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Line, Tumor
  • Drug Carriers / pharmacology
  • Humans
  • Immunogenic Cell Death*
  • Immunotherapy
  • Lipid Bilayers
  • Pancreatic Neoplasms*
  • Tumor Microenvironment

Substances

  • Lipid Bilayers
  • Drug Carriers